December 14, 2006: E-mail from Idani to Jesma Johnson. “I am giving below briefly, direct acts of retaliation, as requested by you.”
March 13, 2007, Idnani was informed by Mr. Ryan Trierweiler, Pfizer Worldwide Pharmaceutical Operations (WPO) Japan/Asia HR, that after a “very thorough investigation” and “having reviewed all relevant evidence in this case it is our determination that no such retaliation is evident and that your termination was for appropriate reasons under both Pfizer policy and local law”.
March 28, 2007: Idnani wrote to Ryan Trierweiler with copy to John Hong, Melanie Trinidad, and Indrani Franchini. “It is apparent that, by default, the Board of Directors - Pfizer Inc and N.Y. Pfizer Leadership Team have condoned, justified and given a clean certificate to . . . in respect of frauds, money laundering, undervaluation of Pfizer assets sold and other misdemeanors/felonies.”
March 29, 2007, John S. Hong, Pfizer Corporate Counsel, International Investigations and Programs in Pfizer’s Legal Division/Corporate Compliance group wrote an e-mail to Idnani: “Thank you for your below feedback, and I ensure you that the allegations which you have raised were treated seriously and reviewed appropriately. As you are aware, an investigation was conducted by a Legal and Audit Compliance team who traveled to India to meet with you and review your concerns. In regards to your requests below, we will not be able to provide you with any documentation related to the investigation of this matter, as that information is privileged and confidential. Regarding the documentation you reference related to the Hyderabad Plant allegation please forward any relevant documents to my attention. You may send them electronically, by mail or via fax, whichever is most convenient, and we will review them accordingly. Lastly, I want to make clear that the Company does not tolerate or condone any misconduct on the part of our colleagues, and I would like to emphasize that considerable time and effort were resourced to thoroughly review your claims.”
March 29, 2006: Idnani wrote back to John Hong. “It is a bit too late to ask me for further documentation on Hyderabad Plant . . . Either, you have not investigated, or there has been deficient investigation . . . I have given documents to Ms. Franchini of payments . . . for detectives, to tail the ex-country manager of Pfizer affiliate.”
April 5, 2007: Idnani wrote email to Jeff Kindler, CEO, Alan Levin, CFO, David Shedlarz, Vice Chairman, with copy to Indrani Franchini, Melanie Trinidad, John Hong and Ryan Trierweiler. He summarized his allegations:
** Undervaluation of manufacturing plant at Hyderabad (frauds and money laundering).
** Undervaluation of residential property at Brighton (frauds and money laundering).
** Unfair and fraudulent accounting (fraud, criminal conspiracy).
** Financial negligence (payments of very excessive advance Income-Tax, later refunded)
** Money laundering activities . . . This activity took place in Pfizer premises. An e-mail detailing the complete fraudulent and racketeering scheme was sent to Mr. John Hong in December 2006 (fraud, money laundering, perjury, tax evasion, criminal conspiracy committed by . . .
** Sending detectives behind litigants and the ex-country manager of a Pfizer Inc. affiliate and possibly to shadow a sitting judge of the high court (unethical, criminal and possibly anti-national behavior).
** Retaliation against me: reducing my grades, freezing of my salary and denial of bonuses for unprecedented four (4) years because I challenged the integrity of . . . and other acts of retaliation.
** Abusing women employees.
April 30, 2007: E-mail from Ryan Trierweiler to Idnani. “As you can see by receipt of various checks over the past couple of weeks I have been working on your behalf to sort out any issues related to your dues. I've also been working with the India site to figure out why these dues were not paid to you sooner.”
May 11, 2007: Idnani contacted Peter Rost. “My name is Ashok S. Idnani. I was a Deputy Manager with Pfizer-India, Finance Division, in Mumbai. I worked with Pfizer-India for 28 years. Suddenly, on August 28, 2006, my services were wrongfully terminated. Cover-up reasons were given immediately after terminating my employment and only after I demanded the reasons. Actually, the termination was in retaliation for reporting to the New York Pfizer Leadership Team in November 2005, a Corporate Compliance Issue for frauds and unfair Accounting.”
May 16, 2007: Pfizer Finance Executive Blows the Whistle - Part One
May 17, 2007: Pfizer Finance Executive Blows the Whistle – Part Two
May 18, 2007: Pfizer Finance Executive Blows the Whistle – Part Three
May 20: Pfizer CFO Alan Levin resigns.
March 13, 2007, Idnani was informed by Mr. Ryan Trierweiler, Pfizer Worldwide Pharmaceutical Operations (WPO) Japan/Asia HR, that after a “very thorough investigation” and “having reviewed all relevant evidence in this case it is our determination that no such retaliation is evident and that your termination was for appropriate reasons under both Pfizer policy and local law”.
March 28, 2007: Idnani wrote to Ryan Trierweiler with copy to John Hong, Melanie Trinidad, and Indrani Franchini. “It is apparent that, by default, the Board of Directors - Pfizer Inc and N.Y. Pfizer Leadership Team have condoned, justified and given a clean certificate to . . . in respect of frauds, money laundering, undervaluation of Pfizer assets sold and other misdemeanors/felonies.”
March 29, 2007, John S. Hong, Pfizer Corporate Counsel, International Investigations and Programs in Pfizer’s Legal Division/Corporate Compliance group wrote an e-mail to Idnani: “Thank you for your below feedback, and I ensure you that the allegations which you have raised were treated seriously and reviewed appropriately. As you are aware, an investigation was conducted by a Legal and Audit Compliance team who traveled to India to meet with you and review your concerns. In regards to your requests below, we will not be able to provide you with any documentation related to the investigation of this matter, as that information is privileged and confidential. Regarding the documentation you reference related to the Hyderabad Plant allegation please forward any relevant documents to my attention. You may send them electronically, by mail or via fax, whichever is most convenient, and we will review them accordingly. Lastly, I want to make clear that the Company does not tolerate or condone any misconduct on the part of our colleagues, and I would like to emphasize that considerable time and effort were resourced to thoroughly review your claims.”
April 5, 2007: Idnani wrote email to Jeff Kindler, CEO, Alan Levin, CFO, David Shedlarz, Vice Chairman, with copy to Indrani Franchini, Melanie Trinidad, John Hong and Ryan Trierweiler. He summarized his allegations:
** Undervaluation of manufacturing plant at Hyderabad (frauds and money laundering).
** Undervaluation of residential property at Brighton (frauds and money laundering).
** Unfair and fraudulent accounting (fraud, criminal conspiracy).
** Financial negligence (payments of very excessive advance Income-Tax, later refunded)
** Money laundering activities . . . This activity took place in Pfizer premises. An e-mail detailing the complete fraudulent and racketeering scheme was sent to Mr. John Hong in December 2006 (fraud, money laundering, perjury, tax evasion, criminal conspiracy committed by . . .
** Sending detectives behind litigants and the ex-country manager of a Pfizer Inc. affiliate and possibly to shadow a sitting judge of the high court (unethical, criminal and possibly anti-national behavior).
** Retaliation against me: reducing my grades, freezing of my salary and denial of bonuses for unprecedented four (4) years because I challenged the integrity of . . . and other acts of retaliation.
** Abusing women employees.
April 30, 2007: E-mail from Ryan Trierweiler to Idnani. “As you can see by receipt of various checks over the past couple of weeks I have been working on your behalf to sort out any issues related to your dues. I've also been working with the India site to figure out why these dues were not paid to you sooner.”
May 11, 2007: Idnani contacted Peter Rost. “My name is Ashok S. Idnani. I was a Deputy Manager with Pfizer-India, Finance Division, in Mumbai. I worked with Pfizer-India for 28 years. Suddenly, on August 28, 2006, my services were wrongfully terminated. Cover-up reasons were given immediately after terminating my employment and only after I demanded the reasons. Actually, the termination was in retaliation for reporting to the New York Pfizer Leadership Team in November 2005, a Corporate Compliance Issue for frauds and unfair Accounting.”
May 16, 2007: Pfizer Finance Executive Blows the Whistle - Part One
May 17, 2007: Pfizer Finance Executive Blows the Whistle – Part Two
May 18, 2007: Pfizer Finance Executive Blows the Whistle – Part Three
May 20: Pfizer CFO Alan Levin resigns.
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).
